MA39077A1 - Combinaison de glycosaminoglycanes et de cyclodextrines - Google Patents

Combinaison de glycosaminoglycanes et de cyclodextrines

Info

Publication number
MA39077A1
MA39077A1 MA39077A MA39077A MA39077A1 MA 39077 A1 MA39077 A1 MA 39077A1 MA 39077 A MA39077 A MA 39077A MA 39077 A MA39077 A MA 39077A MA 39077 A1 MA39077 A1 MA 39077A1
Authority
MA
Morocco
Prior art keywords
combination
cyclodextrins
glycosaminoglycans
treatment
articular
Prior art date
Application number
MA39077A
Other languages
English (en)
Inventor
Angelo Pizzoni
Paolo Pizzoni
Original Assignee
Apharm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apharm Srl filed Critical Apharm Srl
Publication of MA39077A1 publication Critical patent/MA39077A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

L'invention concerne une combinaison injectable de deux parmi les glycosaminoglycanes spécifiques, l'acide hyaluronique et le sulfate de chondroïtine, avec des cyclodextrines et l'utilisation de la combinaison pour le traitement de maladies liées au squelette, en particulier dans le traitement intra-articulaire, ainsi que dans le traitement intradermique.
MA39077A 2013-12-18 2014-12-15 Combinaison de glycosaminoglycanes et de cyclodextrines MA39077A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002116A ITMI20132116A1 (it) 2013-12-18 2013-12-18 Associazione di glicosamminoglicani e ciclodestrine
PCT/IB2014/002774 WO2015092516A1 (fr) 2013-12-18 2014-12-15 Combinaison de glycosaminoglycanes et de cyclodextrines

Publications (1)

Publication Number Publication Date
MA39077A1 true MA39077A1 (fr) 2017-11-30

Family

ID=50115999

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39077A MA39077A1 (fr) 2013-12-18 2014-12-15 Combinaison de glycosaminoglycanes et de cyclodextrines

Country Status (13)

Country Link
US (1) US9974803B2 (fr)
EP (1) EP3082869B1 (fr)
CN (1) CN105899233B (fr)
BR (1) BR112016013834B1 (fr)
CA (1) CA2932987C (fr)
EA (1) EA032372B1 (fr)
ES (1) ES2707971T3 (fr)
IT (1) ITMI20132116A1 (fr)
MA (1) MA39077A1 (fr)
PT (1) PT3082869T (fr)
TN (1) TN2016000206A1 (fr)
TR (1) TR201819270T4 (fr)
WO (1) WO2015092516A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153110A1 (it) * 2015-08-13 2017-02-13 Alfakjn S R L Composizione liquida iniettabile per uso nella terapia infiltrativa intra-articolare
IT201600075246A1 (it) 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
IT201800010415A1 (it) * 2018-11-19 2020-05-19 Innate S R L Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
EP4157290A4 (fr) * 2020-06-02 2024-06-05 National University of Singapore Compositions, leurs utilisations en thérapie et leurs procédés

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282717B6 (sk) * 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
FR2811572B1 (fr) 2000-07-17 2003-04-18 Adir Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ES2493840T3 (es) * 2002-10-07 2014-09-12 Zymogenetics, Inc. Procedimiento de administración de FGF-18
US8455458B2 (en) * 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
CN1451369A (zh) * 2003-03-13 2003-10-29 吉林大学 环糊精衍生物在化妆品中的应用
EP1967186B1 (fr) * 2005-12-27 2015-03-11 Lion Corporation Composition pour lentilles de contact souples et procede permettant la suppression de l' adsorption
CN100594029C (zh) * 2006-07-24 2010-03-17 凌沛学 一种关节腔内注射用药物组合物
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
CN101259139A (zh) * 2008-03-13 2008-09-10 北京阜康仁生物制药科技有限公司 一种用于消炎镇痛的药用组合物
US8466278B2 (en) * 2008-09-22 2013-06-18 Arcarios B.V. Carboxyethylated cyclodextrin polysulfates useful as medicaments
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
CH705713B1 (de) * 2012-09-21 2013-05-15 Labo Cosprophar Ag Dermokosmetische Zusammensetzung zur topischen Anwendung.
CN103301118A (zh) * 2013-06-27 2013-09-18 海南卫康制药(潜山)有限公司 注射用精氨酸布洛芬组合物

Also Published As

Publication number Publication date
TN2016000206A1 (en) 2017-10-06
EP3082869A1 (fr) 2016-10-26
TR201819270T4 (tr) 2019-01-21
CN105899233B (zh) 2020-01-17
BR112016013834B1 (pt) 2022-11-22
CA2932987C (fr) 2021-10-12
US20170035799A1 (en) 2017-02-09
US9974803B2 (en) 2018-05-22
EA032372B1 (ru) 2019-05-31
EP3082869B1 (fr) 2018-10-31
ES2707971T3 (es) 2019-04-08
PT3082869T (pt) 2019-02-06
BR112016013834A2 (fr) 2017-08-08
EA201691246A1 (ru) 2016-10-31
CA2932987A1 (fr) 2015-06-25
WO2015092516A1 (fr) 2015-06-25
ITMI20132116A1 (it) 2015-06-19
CN105899233A (zh) 2016-08-24

Similar Documents

Publication Publication Date Title
EP2951634A4 (fr) Affichage transparent proche de l'oeil avec prescription ophtalmique
MX355080B (es) Mejora de la apariencia de la piel con aumento en la intensidad cromatica de la piel.
BR112014017650A2 (pt) composições e uso de ésteres de forbol
EP2872151A4 (fr) Compositions pro-tolérogènes acellulaires pour le traitement ou la prévention de maladies auto-immunes
MA35365B1 (fr) Pyrimidines annelées substituées et leur utilisation
MX367173B (es) Lentes de contacto de hidrogel de silicona y composiciones y metodos relacionados.
BR112015016608A2 (pt) liga fundida de al
FR3015290B1 (fr) Compositions d'acide hyaluronique compreant de la mepivacaine
EP2967062A4 (fr) Déséthylhydroxychloroquine pour le traitement de maladies associées avec l'inflammation
EA201691828A1 (ru) Прозрачное экструдированное туалетное мыло
MA39077A1 (fr) Combinaison de glycosaminoglycanes et de cyclodextrines
EP2872155A4 (fr) Biomatériaux destinés à améliorer l'intégration de l'implant au sein de l'hôte
MX2013011971A (es) Tratamiento de enfermedades con nanofibras de poli-n-acetil-glucosamina.
IN2015DN00515A (fr)
EP3409292A4 (fr) Composition aqueuse stabilisée comprenant du sulfate de chondroïtine et d'acide hyaluronique
MA41809A (fr) Biotine pour le traitement de la sclérose latérale amyotrophique
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
EP2661272A4 (fr) Salive artificielle comportant de l'acide hyaluronique
IN2014DN06700A (fr)
FR3019465B1 (fr) Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
BR112015019547A2 (pt) pneu tendo uma construção de estrutura desalinhada
MX2015013122A (es) Composiciones hidrofílicas de hialuronato modificado, revestimientos y métodos.
FR3005408B1 (fr) Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette lies aux modifications du tissu adipeux
BR112014012325A2 (pt) fibra de poliolefina
FR2992859A1 (fr) Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes